dc.creatorAertgeerts, Bert
dc.creatorAgoritsas, Thomas
dc.creatorSiemieniuk, Reed A. C.
dc.creatorBrignardello Petersen, Romina
dc.date.accessioned2018-06-29T15:15:36Z
dc.date.accessioned2019-04-26T01:40:01Z
dc.date.available2018-06-29T15:15:36Z
dc.date.available2019-04-26T01:40:01Z
dc.date.created2018-06-29T15:15:36Z
dc.date.issued2017
dc.identifierBMJ 2017;358: j4090
dc.identifier10.1136/bmj.j4090
dc.identifierhttp://repositorio.uchile.cl/handle/2250/149358
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/2453398
dc.description.abstractWhat is the role of a single dose of oral corticosteroids for those with acute sore throat? Using the GRADE framework according to the BMJ Rapid Recommendation process, an expert panel make a weak recommendation in favour of corticosteroid use. The panel produced these recommendations based on a linked systematic review triggered by a large randomised trial published in April 2017. This trial reported that corticosteroids increased the proportion of patients with complete resolution of pain at 48 hours. Box 1 shows all of the articles and evidence linked in this Rapid Recommendation package. The infographic provides the recommendation together with an overview of the absolute benefits and harms of corticosteroids in the standard GRADE format. Table 2 below shows any evidence that has emerged since the publication of this article. Clinicians and their patients can find consultation decision aids to facilitate shared decision making in MAGICapp (www.magicapp.org/goto/guideline/JjXYAL/section/j79pvn).
dc.languageen
dc.publisherBMJ Publishing Group
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile
dc.sourceBMJ British Medical Journal
dc.titleCorticosteroids for sore throat: a clinical practice guideline
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución